These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4281051)

  • 21. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current aspects of seroepidemiological research in combined foci of leishmaniasis].
    Goncharov DB; Saf'ianova VM; Gracheva LI
    Med Parazitol (Mosk); 1993; (1):39-42. PubMed ID: 8336651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the virulent properties of strains of the causative agent of zoonotic cutaneous leishmaniasis in passage via Phlebotomus papatasi].
    Strelkova MV; Alekseev AN; Passova OM
    Med Parazitol (Mosk); 1981; 50(6):19-23. PubMed ID: 7322023
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility of some laboratory and wild mammals to infection by Uzbek strains of Leishmania tropica major isolated from gerbils (Rhombomys opimus Licht.)].
    Ni GV
    Med Parazitol (Mosk); 1966; 35(3):270-4. PubMed ID: 4238258
    [No Abstract]   [Full Text] [Related]  

  • 27. [The extra-burrow activity of the vectors of the causative agents of zoonotic cutaneous leishmaniasis].
    Dergacheva TI; Zherikhina II
    Med Parazitol (Mosk); 1993; (5):37-43. PubMed ID: 8127270
    [No Abstract]   [Full Text] [Related]  

  • 28. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differences in the sensitivity of inbred mice of different lines to Leishmania tropica major].
    Kellina OI
    Med Parazitol (Mosk); 1973; 42(3):279-85. PubMed ID: 4770422
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice.
    Rafati S; Ghaemimanesh F; Zahedifard F
    Vaccine; 2006 Apr; 24(16):3290-7. PubMed ID: 16481076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like.
    Silva Sde O; Wu AA; Evans DA; Vieira LQ; Melo MN
    Acta Trop; 2009 Dec; 112(3):239-48. PubMed ID: 19660430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of host genetics in leishmaniasis.
    Sakthianandeswaren A; Foote SJ; Handman E
    Trends Parasitol; 2009 Aug; 25(8):383-91. PubMed ID: 19617002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Seasonal changes in the population structure of the causative agents of zoonotic cutaneous leishmaniasis in its virulent properties].
    Strelkova MV; Eliseev LN; Passova OM; Kruglov DB
    Med Parazitol (Mosk); 1986; (4):32-8. PubMed ID: 2945084
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intensified virulence of the causative agent in the process of the formation of a focus of cutaneous leishmaniasis].
    Ni GV
    Parazitologiia; 1982; 16(6):452-6. PubMed ID: 6218466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experience of antileishmaniasis vaccinations with cultures of Leishmania tropica major grown in various types of media].
    Shuĭkina EE; Sergiev VP; Triers II; Shcherbakov VA; Diveev SKh
    Med Parazitol (Mosk); 1968; 37(6):648-51. PubMed ID: 4240366
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.
    Preston PM; Carter RL; Leuchars E; Davies AJ; Dumonde DC
    Clin Exp Immunol; 1972 Feb; 10(2):337-57. PubMed ID: 4558410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
    Khoshgoo N; Zahedifard F; Azizi H; Taslimi Y; Alonso MJ; Rafati S
    Vaccine; 2008 Oct; 26(46):5822-9. PubMed ID: 18804512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection of BALB/c, C57B1/6 mice and F1 hybrid CB6F1 mice with strains of Leishmania mexicana isolated from Mexican patients with localized or diffuse cutaneous leishmaniasis.
    Monroy-Ostria A; Fuentes-Fraga I; García-Flores C; Favila-Castillo L
    Arch Med Res; 1994; 25(4):401-6. PubMed ID: 7858398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.